We aimed to appraise the relationship between hematological laboratory tests and the severity of COVID-19 in patients with pre-existing chronic diseases to predict the disease severity. This case-control retrospective study was conducted at Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia, from April to August 2020. Laboratory blood test data of 270 patients with confirmed COVID-19 and admitted to the hospital were enrolled in the study. On the other hand, patients with a respiratory infection, newly diagnosed with a chronic disease, and patients on an anticoagulant were excluded. Patients with no history of chronic disease were grouped into a control group, while the case group included patients with chronic disease. The variances between groups were analyzed by unpaired t-test, while within the groups was paired t-test using SPSS version 19. COVID-19 patients with comorbidities had a higher risk of severe and critical COVID-19 clinical manifestations. Red blood cell and lymphocyte counts were significantly different between the groups at admission (P = 0.012 and 0.027, respectively). Additionally, D-dimer and C-reactive protein (CRP) levels were higher in the comorbid COVID-19 group (64% and 60%, respectively) than in the non-comorbid COVID-19 group. Severe reduction in lymphocyte count and elevation in D-dimer and CRP levels could be potential indicators of COVID-19 severity. These indicators might be helpful in managing patients with chronic diseases.